ACM
KROS icon

ADAR1 Capital Management’s Keros Therapeutics KROS Stock Holding History

ADAR1 Capital Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
97,318
+78,467
+416% +$1.21M 0.06% 151
2025
Q4 		$384K Sell
18,851
-5,370,413
-100% -$94.2M 0.03% 200
2025
Q3 		$85.3M Hold
5,389,264
– – 8.44% 2
2025
Q2 		$71.9M Buy
5,389,264
+3,902,803
+263% +$52.7M 11.68% 1
2025
Q1 		$15.1M Buy
1,486,461
+1,463,215
+6,294% +$17M 2.91% 7
2024
Q4 		$368K Sell
23,246
-421,822
-95% -$21.9M 0.08% 127
2024
Q3 		$25.8M Sell
445,068
-103,848
-19% -$5.13M 4.33% 8
2024
Q2 		$25.1M Buy
548,916
+210,673
+62% +$11.3M 5.05% 7
2024
Q1 		$22.4M Sell
338,243
-350,073
-51% -$20.8M 6.11% 8
2023
Q4 		$27.4M Buy
+688,316
New +$21.6M 12.24% 3

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return